MedPlus margin trails sector peers as other income supports Q2FY27 profit
The consolidated operating margin was 4.00 percentage points below the peer median, while management outlined wider cluster and omni-channel expansion.
Filed 27 Oct 2026, 18:33 IST · after market close · Medplus Health Services Ltd (MEDPLUS)
Key takeaways
- MedPlus reported a consolidated operating margin of 8.35%, 4.00 percentage points below the 12.35% median for 59 Consumer Discretionary peers.
- Consolidated pre-tax profit of Rs 70.15 cr included Rs 20.54 cr of other income, making earnings quality an important read-through.
- Management said it plans to extend sub-two-hour delivery to more locations as part of its expansion and omni-channel strategy.
Price around the results
Q2FY27 margin sits below the peer median
MedPlus reported a consolidated net profit of Rs 56.07 cr, but the more important operating read-through is its 8.35% margin. That was 4.00 percentage points below the 12.35% median for 59 Consumer Discretionary companies that had reported, placing MedPlus 21st from the bottom. With no sequential or year-on-year comparison available, the sector gap provides the clearest benchmark for this quarter.
Other income aided pre-tax profit conversion
The quarter’s consolidated pre-tax profit of Rs 70.15 cr included Rs 20.54 cr of other income, so operating earnings were not the sole contributor to reported pre-tax profit. Interest of Rs 36.62 cr and depreciation of Rs 83.83 cr also reduced the conversion of operating profit into pre-tax profit. The reported tax rate was 20.07%.
Management outlines wider clusters and faster delivery
Management said it plans to deepen its presence in existing clusters and develop new ones, moving from Metro and Tier-One cities to Tier-Two and beyond. It also said it plans to replicate market leadership in locations where it has entered but has not yet attained leadership, while extending sub-two-hour delivery to more locations. The presentation said the company plans to use an omni-channel offering to widen its addressable market and improve retention, and to increase private-label contribution in FMCG products including nutrition and wellness.
Results were filed after market close
MedPlus filed its consolidated Q2FY27 results after market close on 27 October 2026 at 18:33 IST. A post-results stock reaction is therefore not part of this readout.
Q2FY27 at a glance
Consolidated figures as filed with NSE — filed ahead of third-party databases, not yet independently cross-checked.
| Line item | Q2FY27 |
|---|---|
| Revenue | ₹2,037 cr |
| Other income | ₹21 cr |
| Expenses | ₹1,867 cr |
| Operating profit | ₹170 cr |
| Operating margin (%) | 8.35% |
| Interest | ₹37 cr |
| Depreciation | ₹84 cr |
| Profit before tax | ₹70 cr |
| Tax | ₹14 cr |
| Net profit | ₹56 cr |
| EPS (₹) | ₹4.73 |
Operating margin of 8.35% compares with a Consumer Discretionary sector median of 12.35% across 59 peers that have reported Q2FY27.
What management said
From the company’s own investor presentation. Each point is checked against the source document before it appears here.
Guidance & outlook
- MedPlus plans to further grow in cities where it has market leadership.
- MedPlus plans to replicate its leadership in markets where it has entered but has not yet attained market leadership.
- MedPlus plans to extend sub-two-hour delivery to more locations.
Expansion
- MedPlus plans to grow in existing clusters and develop new clusters, progressing from Metro and Tier-One cities to Tier-Two and beyond.
New initiatives
- MedPlus plans to expand its target addressable market through an omni-channel offering.
- MedPlus plans to use omni-channel capabilities to increase customer retention.
- MedPlus plans to increase private-label contribution in FMCG products, including nutrition and wellness.
What to watch
- Whether consolidated operating margin moves from the 8.35% reported in Q2FY27.
- Whether other income remains a material contributor after Rs 20.54 cr this quarter.
- Whether sub-two-hour delivery reaches more locations, as management said it plans.